SEQ ID NO: 14 of Patent CN110785183A

General Information


DCTPep ID  DCTPep06297

Peptide Name   SEQ ID NO: 14 of Patent CN110785183A

Sequence  SYSSCYSF

Sequence Length  8

UniProt ID  Not available

PubChem CID  71587266 

Origin  Synthetic

Type  Synthetic peptide

Classification

  

ACP Cancer targeted peptides Immunotherapeutic peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  HLA-A*24

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  Not available

Predicted Structure  Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C42H54N8O15S1

Absent amino acids  ADEGHIKLMNPQRTVW

Theoretical pI  5.24

Acidic residues  0

Basic residues  0

Polar residues  7

Molecular weight (Average)  943

Molecular weight (Monoisotopic)  942.34

Common amino acids  S

Net charge  0

Instability index (II)  73.58

Aliphatic index  0.00

Grand average of hydropathicity (GRAVY)  -0.062

Half Life 
  1.9 hours (mammalian reticulocytes, in vitro).
  >20 hours (yeast, in vivo).
  >10 hours (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 2980
  Abs 0.1% (=1 g/l) 3.160, assuming all pairs of Cys residues form cystines
  Ext. coefficient 2980
  Abs 0.1% (=1 g/l) 3.160, assuming all Cys residues are reduced

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN110785183A

Patent Title  Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers

Other Iinformation  Not available

Other Published ID  Not available




DCTPep is developed by Dr.Zheng's team.